Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3094% above fair value
$86.06−2.59 (-2.92%)
Close on Nov 17, 2026Market cap $14.65BP/E 96.7Yield –
Solventum pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Solventum's pe ratio was 10.8× on Nov 11, 2026, against 9.8× a year earlier. Over the last 2 years it ranged from 7.4× to 34.9×, with a median of 11.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.8× | +1.7 |
| 2025 | Dec 31, 2025 | 9.1× | −6.8 |
| 2024 | Dec 31, 2024 | 15.9× | – |
See a number that looks wrong?